INSP

Inspire Medical Systems' stock has experienced significant volatility and a notable decline over the past six months (November 2025 - May 2026). Key events impacting the stock include the Q4 2025 earnings release, the Q1 2026 earnings release and guidance cut due to Medicare coding and reimbursement challenges, analyst downgrades and price target cuts following the revised guidance, the Annual General Meeting where stockholders approved an amended incentive award plan and governance changes, and a proposed class action lawsuit alleging that Inspire misled investors about the readiness and demand for its Inspire V launch.